植込型補助人工心臓がもたらす ... - jsao.org

← Back to document page

1 2 . 3 . 1 2 3. Tomoyuki TAKURA, Shunei KYO, Yoshiki SAWA. . 1. . . value . function cost . . performance value . . . outcome . utility 1 . . . . . . . well- being . . . outcome cost . . performance value . socioeconomics . . . 2. . . 1 . 1) . . 2 . . 2 . 1 . utility . 565-0871 2-2 . E-mail. . 41 1 2012 93. Cost utility utility year Qalys (-). Therapy(+) Doubtful Dominant Cost Utility Cost Utility . base Survival time (quantitative profit), Quality of Utility U t ility life (qualitative (-) ( +). profit). Therapy(-). Inferior Effective pre treatment post . Cost Utility Cost Utility . time . 1 consideration Cost in press 2) . (+). ICUR Performances are compared between medical technology Value of medicine is discussed with acceptance of public health insurance 2 . utility 2 Incremental Cost Utility Ratio ICUR . . 1 1340: 16-7, 2009 3). . Qaly: quality adjusted life years . 1 2) . / willingness to pay 2 . . . . 1 1 Qaly 3 5 US$ . . 1 . . 4) Qaly . incremental cost utility ratio: ICUR.

特集「植込型補助人工心臓の時代を迎えて」 人工臓器41巻1号 2012年 93 著者連絡先 大阪大学大学院医学系研究科医療経済産業政策学

  Jaso